Literature DB >> 26638963

Primary chemotherapy versus primary surgery for ovarian cancer - Authors' reply.

Sean Kehoe1, Matthew Nankivell2.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26638963     DOI： 10.1016/S0140-6736(15)01052-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

1.  Optimal primary management of bulky stage IIIC ovarian, fallopian tube and peritoneal carcinoma: Are the only options complete gross resection at primary debulking surgery or neoadjuvant chemotherapy?

Authors:  Vasileios D Sioulas; Maria B Schiavone; David Kadouri; Oliver Zivanovic; Kara Long Roche; Roisin O'Cearbhaill; Nadeem R Abu-Rustum; Douglas A Levine; Yukio Sonoda; Ginger J Gardner; Mario M Leitao; Dennis S Chi
Journal:  Gynecol Oncol       Date:  2017-02-21       Impact factor: 5.482

Review 2.  Imaging and therapy of ovarian cancer: clinical application of nanoparticles and future perspectives.

Authors:  Giovanni Di Lorenzo; Giuseppe Ricci; Giovanni Maria Severini; Federico Romano; Stefania Biffi
Journal:  Theranostics       Date:  2018-07-30       Impact factor: 11.556

3.  Overcoming platinum resistance in ovarian cancer by targeting pregnancy-associated plasma protein-A.

Authors:  Diogo Torres; Xiaonan Hou; Laurie Bale; Ethan P Heinzen; Matthew J Maurer; Valentina Zanfagnin; Ann L Oberg; Cheryl Conover; S John Weroha
Journal:  PLoS One       Date:  2019-11-21       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.